49
NPS Score
VS
Intellia Therapeutics Claimed Company
- EMPLOYEE
PARTICIPANTS - 12
- TOTAL
RATINGS
Vertex Pharmaceuticals Claimed Company
- EMPLOYEE
PARTICIPANTS - 84
- TOTAL
RATINGS
Intellia Therapeutics vs Vertex Pharmaceuticals
Compare Intellia Therapeutics versus Vertex Pharmaceuticals for CEO Rating, Overall Culture Score, Brand Ranking, and other ratings. Results were generated by 12 employees and customers of Intellia Therapeutics and 84 employees and customers of Vertex Pharmaceuticals.
Intellia Therapeutics
Intellia Therapeutics's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Intellia Therapeutics. Their current market cap is $5.42B.
Vertex Pharmaceuticals
Vertex Pharmaceuticals's brand is ranked #- in the list of Global Top 1000 Brands, as rated by customers of Vertex Pharmaceuticals. Their current market cap is $89.62B.
3.5/5
Product Quality
3.5/5
3.3/5
Pricing
4/5
3.9/5
Customer Service
3.9/5
| 66% | Promoters |
|---|---|
| 17% | Passive |
| 17% | Detractors |
Net Promoter Score
Winner by 14
35
NPS Score
| 60% | Promoters |
|---|---|
| 15% | Passive |
| 25% | Detractors |
See how Intellia Therapeutics compares to its competitors
See how Vertex Pharmaceuticals compares to its competitors
Working at Intellia Therapeutics vs Working at Vertex Pharmaceuticals
86 / 100
CEO Rating
Winner by 4%
82 / 100
CEO Rating
Intellia Therapeutics
Intellia Therapeutics doesn't have enough ratings to calculate the Team Culture Ratings.
Know someone that works there? Invite them to rate their experience.
Vertex Pharmaceuticals
Employees at Vertex Pharmaceuticals rate their CEO, Reshma Kewalramani, 82/100. This score is 4% lower than the scores of Intellia Therapeutics' CEO, John Leonard. Employees in the HR and Finance departments rate Reshma Kewalramani the highest.